Countering weapons of mass destruction is “an enduring mission of the U.S. Armed forces,” the US Army said last week in a new doctrinal publication.
Counter-WMD operations are defined as actions taken “against actors of concern to curtail the research, development, possession, proliferation, use, and effects of WMD, related expertise, materials, technologies, and means of delivery.”
See Combined Arms Countering Weapons of Mass Destruction, ATP 3-90.40, June 29, 2017.
The Army document does not refer to any specific countries such as North Korea.
Instead, it says generally that “Conventional forces and SOF [special operations forces] capabilities may be necessary to stop the movement of CBRN materials, WMD components and means of delivery, WMD-related personnel, or functional weapons into or out of specified areas or nations. Such actions may require boarding vessels and using search and detection capabilities to secure and seize shipments.”
Counter-WMD activities are directed not only at the weapons themselves but at the networks that produce, sponsor, fund and utilize them.
“Interacting with and engaging networks requires the use of lethal and nonlethal means to support, influence, or neutralize network members, cells, or an entire network. As part of this effort, commanders select, prioritize, and match effective means of interacting with friendly networks, influencing the neutral network, and neutralizing threat networks,” the new Army publication said.
“Commanders and staff utilize the targeting process to identify targets, determine the desired effects on those targets, predict secondary and tertiary effects, and plan lethal and nonlethal effects. This process enables the prosecution of targets to capitalize on and exploit targets of opportunity.”
Our analysis of federal AI governance across administrations shows that divergent compliance procedures and uneven institutional capacity challenge the government’s ability to deploy AI in ways that uphold public trust.
From California to New Jersey, wildfires are taking a toll—costing the United States up to $424 billion annually and displacing tens of thousands of people. Congress needs solutions.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.